Tenon Medical, Inc. Stock Issued During Period, Value, Conversion of Units
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Tenon Medical, Inc. stock issued during period, value, conversion of units for the quarter ending 2024-06-30 was $0.00.
- Tenon Medical, Inc. stock issued during period, value, conversion of units for the quarter ending 2024-03-31 was -$3.55M.
- Tenon Medical, Inc. stock issued during period, value, conversion of units for the quarter ending 2022-12-31 was -$13.64M.
- Tenon Medical, Inc. stock issued during period, value, conversion of units for the quarter ending 2022-09-30 was $0.00.
- Tenon Medical, Inc. stock issued during period, value, conversion of units for fiscal 2022 was -$12.37M.
| Period end | Stock Issued During Period, Value, Conversion of Units 3 month | Stock Issued During Period, Value, Conversion of Units 12 month |
|---|---|---|
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | |
| 2024-03-31 | -$3.55M 10-Q · filed 2024-05-15 | |
| 2022-12-31 | -$13.64M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -$12.37M 10-K · filed 2024-03-29 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | |
| 2022-06-30 | $1.27M 10-Q · filed 2023-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |